Qianyuan Yiyao (Shanghai) Pharmaceutical Co., Ltd. Files Prospectus for AI-Driven Innovative Drug Development

36Kr learned that the Aiqicha App shows that recently, Qianyuan Yiyao (Shanghai) Pharmaceutical Co., Ltd. was established, with HUANG, LE-QUN LEE as the legal representative. The registered capital is 120 million yuan, and its business scope includes technical services, technical development, technical consultation, technical exchange, technical transfer, and technical promotion. Shareholder information shows that the company is jointly held by Shanxi C&Y Pharmaceutical Co Ltd and GigaCeuticals.Original Link